glaxosmithkline - Latest News on glaxosmithkline | Read Breaking News on Zee News

GlaxoSmithKline seeks FIPB nod to hike stake in Indian arm

Last Updated: Sunday, January 05, 2014, 13:24

UK-based drug major GlaxoSmithKline is knocking at the FIPB's doors to raise stake in its India arm by acquiring an additional 24.33 percent for around Rs 6,400 crore.

Global FMCG majors bet big on India despite slowdown

Last Updated: Wednesday, December 25, 2013, 12:16

Unilever, GlaxoSmithKline and PepsiCo made big bang announcements during the year as they decided to enhance their play in the "strategic and emerging" Indian market.

GSK Pharma gains 19% on parent co's move to make open offer

Last Updated: Monday, December 16, 2013, 18:38

At the NSE, the stock shot-up by 18.90 percent to close the trade at Rs 2,925.

GSK Pharma rallies 20% as parent company launches open offer

Last Updated: Monday, December 16, 2013, 12:33

Shares of GlaxoSmithkline Pharmaceuticals today skyrocketed by 20 percent after UK-based GlaxoSmithKline Plc announced a voluntary open offer to increase stake in its Indian subsidiary.

GlaxoSmithKline Pharmaceuticals for bn-dollar buyback in GSK India

Last Updated: Monday, December 16, 2013, 09:30

GlaxoSmithKline Plc (GSK) is looking at hiking stake in GlaxoSmithKline Pharmaceuticals to up to 75 percent from 50.67 percent, in line with FMCG giant Unilever increasing stake in its Indian arm HUL earlier this year.

GlaxoSmithKline Q3 Net declines 33.73% to Rs 100.95 cr

Last Updated: Monday, November 11, 2013, 13:40

Drug firm GlaxoSmithKline Pharmaceuticals (GSK) on Monday reported 33.73 percent decline in standalone net profit at Rs 100.95 crore for the third quarter ended September 30, 2013.

GSK Consumer Healthcare Q3 Net up 14.29% at Rs 146.93 crore

Last Updated: Wednesday, November 06, 2013, 16:01

GlaxoSmithKline (GSK) Consumer Healthcare Ltd reported 14.29 per cent increase in standalone net profit at Rs 146.93 crore for the third quarter ended September 30, aided by higher sales.

Glaxo says China drugs sales slump on bribery probe

Last Updated: Wednesday, October 23, 2013, 18:36

British pharmaceuticals giant GlaxoSmithKline announced on Wednesday a drop in quarterly net profits, while sales slumped in China where the group has been rocked by a state bribery probe.

Japan's Suntory to buy GSK drink brands for $2.1 bn

Last Updated: Monday, September 09, 2013, 22:07

Japanese drinks giant Suntory said Monday it would buy the top-selling Lucozade and Ribena brands from British drugs firm GlaxoSmithKline (GSK) for USD 2.1 billion.

GSK loses patent claim on breast cancer drug Tykerb

Last Updated: Friday, August 02, 2013, 12:41

The Intellectual Property Appellate Board (IPAB) has revoked the patent granted to the British drug major GlaxoSmithKline Pharma for its breast cancer drug -- Tykerb.

GSK says China bribes probe to hit performance

Last Updated: Wednesday, July 24, 2013, 19:07

GlaxoSmithKline expects its financial performance in China to take a hit from Beijing's probe into bribery allegedly carried out by senior staff, the British pharmaceuticals company said Wednesday.

GlaxoSmithKline admits China executives bribed doctors for boosting sales

Last Updated: Tuesday, July 23, 2013, 17:39

GlaxoSmithKline (GSK) has acknowledged that some senior employees in the firm were allegedly involved in a bribing scandal of doctors prescribing the firm's drugs in China.